Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Shanghai OPM Biosciences Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	352.45	296.78	242.69	294.27	212.68	124.97
Other Revenue	0.47	0.47	0.43	0.1	-	-
Revenue	352.91	297.24	243.12	294.37	212.68	124.97
Revenue Growth (YoY)	22.84%	22.26%	-17.41%	38.41%	70.19%	113.55%
Cost of Revenue	173.86	142.34	101.53	107.25	86	68.01
Gross Profit	179.06	154.9	141.59	187.12	126.69	56.96
Selling, General & Admin	92.61	105.94	74.47	60	50.96	29.69
Research & Development	45.75	33.37	41.91	32.19	19.03	20.51
Other Operating Expenses	3.86	2.21	-0.23	1.17	0.78	0.17
Operating Expenses	144.27	148.44	122.57	98.11	71.09	50.47
Operating Income	34.79	6.46	19.02	89	55.6	6.49
Interest Expense	-0.74	-3.12	-3.23	-4.98	-4.79	-2.45
Interest & Investment Income	26.24	31.14	36.3	17.98	9.07	3.56
Currency Exchange Gain (Loss)	2.4	2.4	0.87	2.24	-0.24	-0.53
Other Non Operating Income (Expenses)	15.58	-0.05	-0.09	-0.14	-0.07	-0.15
EBT Excluding Unusual Items	78.28	36.84	52.89	104.09	59.57	6.91
Gain (Loss) on Sale of Investments	-1.54	4.63	1.53	1.67	-	-
Gain (Loss) on Sale of Assets	0.01	0.09	-0.02	0.29	-0.02	-
Asset Writedown	-10.67	-7.51	-	-	-	-0
Other Unusual Items	0.04	2.38	7.26	13.38	8.61	4.77
Pretax Income	66.11	36.43	61.67	119.43	68.15	11.68
Income Tax Expense	23.46	16.19	8.41	14.06	7.76	-
Earnings From Continuing Operations	42.66	20.24	53.26	105.37	60.39	11.68
Minority Interest in Earnings	0.59	0.82	0.78	-	-	-
Net Income	43.24	21.05	54.04	105.37	60.39	11.68
Net Income to Common	43.24	21.05	54.04	105.37	60.39	11.68
Net Income Growth	13.53%	-61.04%	-48.72%	74.47%	416.87%	-
Shares Outstanding (Basic)	110	111	115	101	86	86
Shares Outstanding (Diluted)	118	117	115	101	86	86
Shares Change (YoY)	2.79%	1.72%	13.48%	17.43%	0.20%	-
EPS (Basic)	0.39	0.19	0.47	1.04	0.70	0.14
EPS (Diluted)	0.37	0.18	0.47	1.04	0.70	0.14
EPS Growth	10.45%	-61.70%	-54.81%	48.57%	415.84%	-
Free Cash Flow	21.21	-51.61	-19.59	-35.34	8.64	-33.04
Free Cash Flow Per Share	0.18	-0.44	-0.17	-0.35	0.10	-0.38
Dividend Per Share	0.200	0.420	0.440	0.429	-	-
Dividend Growth	-55.59%	-4.47%	2.66%	-	-	-
Gross Margin	50.74%	52.11%	58.24%	63.57%	59.56%	45.58%
Operating Margin	9.86%	2.17%	7.82%	30.23%	26.14%	5.19%
Profit Margin	12.25%	7.08%	22.23%	35.80%	28.40%	9.35%
Free Cash Flow Margin	6.01%	-17.36%	-8.06%	-12.01%	4.06%	-26.44%
EBITDA	76.36	42.22	47.04	113.28	74.34	21.98
EBITDA Margin	21.64%	14.21%	19.35%	38.48%	34.96%	17.58%
D&A For EBITDA	41.57	35.76	28.02	24.28	18.74	15.49
EBIT	34.79	6.46	19.02	89	55.6	6.49
EBIT Margin	9.86%	2.17%	7.82%	30.23%	26.14%	5.19%
Effective Tax Rate	35.48%	44.45%	13.63%	11.78%	11.39%	-
Revenue as Reported	81.39	297.24	243.12	294.37	212.68	124.97
Advertising Expenses	-	2.08	2.29	1.34	0.73	0.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.